Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

ONE DAY left in this Mid-Year Campaign. This is our hour of need.
If you value independent journalism, please support Common Dreams.

Join the small group of generous readers who donate, keeping Common Dreams free for millions of people each year. Without your help, we won’t survive.

Demonstrators hold a rally in Washington, D.C. urging the U.S. to commit to a global coronavirus vaccination plan that includes sharing vaccine formulas with the world on May 5, 2021.

Demonstrators hold a rally in Washington, D.C. urging the U.S. to commit to a global coronavirus vaccination plan that includes sharing vaccine formulas with the world on May 5, 2021. (Photo: Saul Loeb/AFP via Getty Images)

'Cry No Tears for These Death Profiteers': Pharma Stocks Plunge as Biden Backs Vaccine Patent Waiver

"It's almost as if the financial interests of the pharmaceutical industry are diametrically opposed to the health and well-being of the planet."

Jake Johnson

Stocks of major pharmaceutical corporations plummeted Wednesday after the Biden administration announced its support for a coronavirus vaccine patent waiver, a measure that would free vaccine recipes from Big Pharma's stranglehold and help enable generic manufacturers to ramp up global production.

As CNBC reported, shares in Pfizer, BioNTech, Novavax, and Moderna fell to "session lows" after the Biden White House endorsed the waiver—a potentially seismic move that came after weeks of tireless campaigning by progressive lawmakers and advocacy groups.

Canada, European Union member nations, the United Kingdom, and other wealthy countries remain opposed to the waiver, leaving the chances of consensus approval at the World Trade Organization highly uncertain.

Nevertheless, the Biden administration's support for the waiver spooked investors and infuriated the pharmaceutical industry, which has been lobbying hard against the proposal in an effort to preserve its immensely profitable monopoly control over vaccine production.

"Cry no tears for these death profiteers," environmentalist and author Naomi Klein tweeted in response to a CNBC graphic showing the major sell-off of pharma shares on Wednesday.

"It's almost as if the financial interests of the pharmaceutical industry are diametrically opposed to the health and well-being of the planet," added consumer watchdog Public Citizen, part of a broad coalition of global civil society groups that has been pushing U.S. President Joe Biden and other world leaders to back the patent waiver for months.

The Financial Times reported Thursday morning that the Biden administration's decision to back the temporary intellectual property waiver—which South Africa and India first introduced at the WTO in October—"prompted instant outrage in the pharmaceutical sector."

"Shares in the big makers of Covid-19 vaccines were hit by the announcement," FT noted. "Frankfurt-listed shares in BioNTech lost 14 percent on Thursday. Moderna and Novavax closed down by between 3 percent and 6 percent in New York the day before."

Warren Gunnels, staff director for Sen. Bernie Sanders (I-Vt.), said Wednesday that "after taxpayers paid Pfizer, BioNTech, Novavax, and Moderna $13.5 billion for Covid-19 vaccines, seven executives at these firms became billionaires and are now worth $17.2 billion."

"No one should have gotten wealthy off of these vaccines," Gunnels added. "They belong to the people, not billionaires."

Allowing a handful of pharmaceutical companies to dictate global supply of life-saving coronavirus vaccines has been disastrous for much of the developing world, which has struggled to obtain and administer doses after profit-seeking drugmakers sold most of their early production to wealthy countries.

Now, as cities in rich nations accelerate their reopenings amid stagnant or falling case counts, skyrocketing infections in developing countries such as India, Brazil, and Thailand are pushing global case counts to a new peak, intensifying calls for sweeping action to boost vaccine production and distribution.

While insufficient to solve global production shortages on its own, India and South Africa's patent waiver would lift a key legal barrier that's preventing manufacturers around the world from copying existing vaccine recipes and mass-producing generic versions.

"In the many months since this waiver was first proposed, we could have produced many hundreds of millions more vaccines," Nick Dearden, director of the London-based advocacy group Global Justice Now, said in a statement Wednesday. "Let's get moving."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

Just ONE DAY left in our crucial Mid-Year Campaign and we might not make it without your help.
Who funds our independent journalism? Readers like you who believe in our mission: To inform. To inspire. To ignite change for the common good. No corporate advertisers. No billionaire founder. Our non-partisan, nonprofit media model has only one source of revenue: The people who read and value this work and our mission. That's it.
And the model is simple: If everyone just gives whatever amount they can afford and think is reasonable—$3, $9, $29, or more—we can continue. If not enough do, we go dark.

All the small gifts add up to something otherwise impossible. Please join us today. Donate to Common Dreams. This is crunch time. We need you now.

As US Rolls Back Reproductive Rights, Sierra Leone Moves to Decriminalize Abortion

"I'm hopeful today's announcement gives activists in the U.S., and especially Black women given the shared history, a restored faith that change is possible and progress can be made."

Brett Wilkins ·


'Indefensible': Outrage as New Reporting Shines Light on Biden Deal With McConnell

The president has reportedly agreed to nominate an anti-abortion Republican to a lifetime judgeship. In exchange, McConnell has vowed to stop blocking two Biden picks for term-limited U.S. attorney posts.

Jake Johnson ·


Assange Makes Final Appeal Against US Extradition

"If Julian Assange is not free, neither are we," said a protester at a Friday demonstration against the WikiLeaks founder's impending transfer. "None of us is free."

Brett Wilkins ·


'Payoff for 40 Years of Dark Money': Supreme Court Delivers for Corporate America

"It was the conservative court's larger agenda to gut the regulatory state and decimate executive powers to protect Americans' health and safety," warned one expert.

Jake Johnson ·


NARAL Pro-Choice Endorses Fetterman—Who Vows to End Senate Filibuster to Protect Abortion Rights

"We know we can count on him to boldly fight for abortion rights and access," said the head of one of the nation's largest reproductive rights advocacy groups.

Jon Queally ·

Common Dreams Logo